InvestorsHub Logo
icon url

bidrite

11/08/13 9:34 AM

#147821 RE: PhoenixRising #147820

First Paragraph

Phosphatidylserine (PS) and CTLA-4 Targeting Antibody Combination Stopped Tumor Growth in 100% of Animals in Preclinical Melanoma

icon url

TekNuLoof

11/08/13 9:35 AM

#147823 RE: PhoenixRising #147820

Phosphatidylserine (PS) and CTLA-4 Targeting Antibody Combination Stopped Tumor Growth in 100% of Animals in Preclinical Melanoma Model

icon url

jimsgtx

11/08/13 9:35 AM

#147825 RE: PhoenixRising #147820

Phosphatidylserine (PS) and CTLA-4 Targeting Antibody Combination Stopped Tumor Growth in 100% of Animals in Preclinical Melanoma Model; Planning Underway for Near-Term Phase I Clinical Trial Evaluating Bavituximab and Anti-CTLA-4 Combination Immunotherapy in Patients With Advanced Melanoma

http://finance.yahoo.com/news/data-presentation-society-immunotherapy-cancer-140000113.html